FDA Clears 31 New Molecular Entities In 2004, Up Ten From Previous Year
Pfizer's Lyrica (pregabalin) is the final NME of the year. Over 20% of the approvals came in the last two weeks of December.
Pfizer's Lyrica (pregabalin) is the final NME of the year. Over 20% of the approvals came in the last two weeks of December.